HRAS and neoplasm: Correlation with the tumour pathology showed that the CUP cases with morphology of adenocarcinoma and PD carcinoma had the largest number of cell signalling pathway variants (EGFR, MET, JAK3, KRAS, HRAS, BRAF, PIK3CA, PTPN11 and APC).